Nicotine-mecamylamine treatment for smoking cessation: The role of pre-cessation therapy.
Rose, Jed E., Behm, Frederique M., Westman, Eric C.·1998·Experimental and Clinical Psychopharmacology
Cited by (21)
- Nicotine replacement therapy for smoking cessationStead, Lindsay F, Perera, Rafael, Bullen, Chris, Mant, David, Hartmann-Boyce, Jamie, Cahill, Kate, Lancaster, Tim · 2012 · Cochrane Database of Systematic Reviews
- Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>Gonzales, David · 2006 · JAMA
- Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking CessationCoe, Jotham W., Brooks, Paige R., Vetelino, Michael G., Wirtz, Michael C., Arnold, Eric P., Huang, Jianhua, Sands, Steven B., Davis, Thomas I., Lebel, Lorraine A., Fox, Carol B. et al. · 2005 · Journal of Medicinal Chemistry
- Nicotine replacement therapy for smoking cessationStead, Lindsay F, Perera, Rafael, Bullen, Chris, Mant, David, Lancaster, Tim · 2008 · Cochrane Database of Systematic Reviews
- Applying extinction research and theory to cue‐exposure addiction treatmentsConklin, Cynthia A., Tiffany, Stephen T. · 2002 · Addiction
- Rationale, pharmacology and clinical efficacy of partial agonists of α4β2 nACh receptors for smoking cessationRollema, Hans, Coe, Jotham W., Chambers, Leslie K., Hurst, Raymond S., Stahl, Stephen M., Williams, Kathryn E. · 2007 · Trends in Pharmacological Sciences
- Smoking Cessation With Varenicline, a Selective α4β2 Nicotinic Receptor Partial Agonist: Results From a 7-Week, Randomized, Placebo- and Bupropion-Controlled Trial With 1-Year Follow-upNides, Mitchell · 2006 · Archives of Internal Medicine
- Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessationOncken, Cheryl · 2006 · Archives of Internal Medicine
- Nicotine and nonnicotine factors in cigarette addictionRose, Jed E. · 2006 · Psychopharmacology
- Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trialAubin, H-J, Bobak, A, Britton, J R, Oncken, C, Billing, C B, Gong, J, Williams, K E, Reeves, K R · 2008 · Thorax
- Us Public Health Service Clinical Practice Guideline: Treating Tobacco Use and DependenceFiore, Michael C, Guideline Panel and Staff · 2000 · Respiratory Care
- Interventions for preventing weight gain after smoking cessationFarley, Amanda C, Hajek, Peter, Lycett, Deborah, Aveyard, Paul · 2012 · Cochrane Database of Systematic Reviews
- Nicotinic acetylcholine receptors as targets for antidepressantsShytle, R D, Silver, A A, Lukas, R J, Newman, M B, Sheehan, D V, Sanberg, P R · 2002 · Molecular Psychiatry
- Analysis of Mecamylamine Stereoisomers on Human Nicotinic Receptor SubtypesPapke, Roger L., Sanberg, Paul R., Shytle, R. Douglas · 2001 · The Journal of Pharmacology and Experimental Therapeutics
- Monoamine transporters and psychostimulant addictionHowell, Leonard L., Kimmel, Heather L. · 2008 · Biochemical Pharmacology
- Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessationLindson, Nicola, Chepkin, Samantha C, Ye, Weiyu, Fanshawe, Thomas R, Bullen, Chris, Hartmann-Boyce, Jamie · 2019 · Cochrane Database of Systematic Reviews
- Nicotine Replacement Therapy : An OverviewWadgave, Umesh, L., Nagesh · 2016 · International Journal of Health Sciences
- Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disordersBacher, Ingrid, Wu, Becky, Shytle, Douglas R, George, Tony P · 2009 · Expert Opinion on Pharmacotherapy
- Nicotine patch therapy prior to quitting smoking: a meta‐analysisShiffman, Saul, Ferguson, Stuart G. · 2008 · Addiction
- Effects of sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) ratsRezvani, Amir H., Slade, Susan, Wells, Cori, Petro, Ann, Lumeng, Lawrence, Li, Ting-Kai, Xiao, Yingxian, Brown, Milton L., Paige, Mikell A., McDowell, Brian E. et al. · 2010 · Psychopharmacology
- Comorbid bipolar disorder in Tourette’s syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine)Shytle, R.Douglas, Silver, Archie A, Sanberg, Paul R · 2000 · Biological Psychiatry
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.